Molecular profiling of renal cell carcinoma: Building a bridge toward clinical impact
Academic Article
Overview
MeSH Major
Kidney
Nephrectomy
Tumor Burden
abstract
The molecular and genomic profiling of RCC subtypes has identified a unique and diverse spectrum of alterations. Utilization of these characteristics to improve our prognostic and therapeutic outcomes in the clinical realm remains in its infancy but is rapidly advancing.